Breaking AI & Tech News Analyzed

The traditional No 9 striker, once a cornerstone of football, is becoming increasingly obsolete. The partnership of Andy Cole and Dwight Yorke at Manchester United in the late 1990s exemplifies a bygone era when strikers were the main goal-scoring threats. Today, the Premier League's leading scorers are more likely to be wingers, No 10s, or false 9s.Data from Opta shows that strikers scored 41.6% of the Premier League's goals two decades ago, compared to 25.9% this season. The decline of traditional center-forwards is further evidenced by the decrease in standout individual striker performances. Between 2007 and 2012, there were four seasons with 10 or more hat-tricks by center-forwards; in the past nine seasons, this threshold has been met only once.The England national team faces a significant challenge with Harry Kane, their all-time leading scorer, approaching retirement. Beyond Kane, the options are limited, with Dominic Solanke and Dominic Calvert-Lewin failing to impress. The lack of quality strikers raises concerns about England's future prospects.Experts attribute the decline of the No 9 to the redefinition of the role and the increased emphasis on possession-based football. Emile Heskey notes that the traditional striker's job has changed, with more focus on creating space for other players. René Meulensteen argues that specialized striker training is essential to develop No 9s, but such training has been neglected in favor of more generalized sessions.However, there is hope that a successful team utilizing a lethal strike partnership could revive demand for traditional No 9s. Dean Whitehouse believes that if a manager starts winning trophies with paired strikers, other teams will follow suit, and the demand for No 9s will return. The abundance of technically gifted players, fostered by initiatives like Gareth Southgate's push for smaller-sided games at youth level, may yet lead to a resurgence of the traditional No 9.

LIV Golf is shifting its focus from recruiting individual stars to securing whole tournaments, with the Saudi‑funded circuit now eyeing the possibility of hosting traditional national open championships. This strategic pivot could reshape the ongoing power tussle in elite golf. The proposal threatens the DP World Tour—formerly the European Tour—which already boasts a dense calendar of national opens across Europe and emerging markets like China, India and Australia. Adding more of these marquee events to LIV’s roster would intensify competition for the most coveted tournament slots. Although the recent exodus of top players from established tours to LIV appears to have stalled or even reversed, the battle for prime tournament markets is far from settled. Securing historic national opens would give LIV a foothold in events that carry deep cultural and commercial weight. To date, LIV has built a largely international schedule, staging events in Australia, South Africa, Mexico City, Hong Kong and Singapore for the 2026 season. While these locations broaden the circuit’s global reach, none possess the longstanding prestige of a national open. By contrast, the DP World Tour has successfully leveraged national opens to expand its brand beyond Europe, tapping audiences in Asia and the Pacific. This experience underscores the strategic value of such tournaments for sponsors and broadcasters. Meanwhile, the DP World Tour is engaged in high‑level negotiations with the PGA Tour to extend a strategic alliance that currently runs until the end of 2027. The PGA is reportedly pushing for a reduced annual financial underpin for DP World prize funds, and the emerging threat from LIV is a key bargaining chip in those talks. Recent player movements have added nuance to the rivalry: the PGA Tour welcomed back Brooks Koepka and Patrick Reed after their departures to LIV, yet the Saudi Public Investment Fund shows no sign of scaling back its ambitious golf project. On the player front, Jon Rahm, who remains with LIV, is slated to address the media at Augusta National ahead of the Masters. Having lost an appeal over fines imposed for playing on LIV, Rahm is currently barred from the Ryder Cup and has refused to settle the penalties, leaving him in strained relations with the DP World Tour. His comments are expected to dominate the pre‑Masters press conference.

James, the Manchester‑originated nine‑piece, have turned a five‑decade career into a living testament to longevity, headlining arenas while celebrating the surprise success of their 2024 album Yummy, which finally secured a UK No.1 spot 42 years after the band first formed.The group continues to defy conventional touring formulas. Frontman Tim Booth describes their shows as “crazy, idiosyncratic,” with nightly set‑list revisions and unreleased songs that often lack finished lyrics. One such piece, the eight‑minute “Nantucket,” features a wordless chorus, an electro‑violin groove and verses that proclaim a mission to inspire, embodying the band’s experimental spirit.Rather than relying solely on a greatest‑hits marathon, the two‑hour, 21‑song performance weaves in moody interludes, deep‑cut selections, and influences ranging from Brian Eno’s ambient textures to the pulsating beats of Italian house. Lyrical barbs aimed at billionaires and organized religion sit alongside anthemic warmth, creating a communal atmosphere. The opening number “Come Home” subtly nods to Booth’s Leeds roots, while trumpeter Andy Diagram sports a “No more war” T‑shirt, and Booth often reaches out to audience members, reinforcing the show’s inclusive vibe.Driving the rhythm is veteran drummer David Baynton‑Power, complemented by recent additions Chloe Alper and Debbie Knox‑Hewson, who inject fresh sonic layers. Booth, now 66, remains the band’s charismatic talisman, occasionally appearing on a balcony for “Born of Frustration” and the soaring “Say Something,” moments that feel almost ritualistic. Arena‑sized sing‑alongs erupt during “Getting Away With It (All Messed Up)” and the classic “Sit Down,” and when Booth finally dives off the stage, he is hoisted aloft by a sea of hands, underscoring the band’s unique connection with fans.The concert at P&J Live in Aberdeen on 7 April exemplified why James remains a special, brilliant force in live music, continuing a tour that proves their relevance and humanity endure across generations.

David Attenborough is set to dazzle audiences with his sparkling new series on BBC One, showcasing the wonders of wildlife living right under our noses. The series begins in Oxfordshire, where Attenborough discovers scampering voles and talking duck eggs.Meanwhile, on Channel 4, The Great Celebrity Bake Off for Stand Up to Cancer challenges celebrities to conjure up mini rolls and syrup sponge puddings, with a showstopper involving recreating their best looks in choux pastry form.Other highlights include The Other Bennet Sister on BBC One, The Capture on BBC One, and Pilgrimage: The Road to Holy Island on BBC Two. Film enthusiasts can look forward to Being There on BBC Two at 11:50pm.For sports fans, Women’s FA Cup Football matches are scheduled on TNT Sports 1 and Channel 4.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

Leeds United travel to West Ham for an FA Cup quarter‑final that both clubs would prefer to avoid, yet manager Daniel Farke is clear about his priorities. With an MA in economics and a diploma in sporting directorship, he stresses that Premier League survival is the club’s "bread and butter" and must come first.Off the pitch, the German‑born coach unwinds by immersing himself in literary fiction, counting Gabriel García Márquez’s One Hundred Years of Solitude among his favourites.Farke’s dual role as a tactician and a storyteller raises the question of whether he can engineer a season that delivers both survival and cup glory. A successful double could make it hard for the Elland Road hierarchy to deny him the new contract he desires."I’m a big believer in cup competitions," Farke said, emphasizing that Leeds will approach the West Ham tie "very, very seriously". He added that the squad will start strong unless a player shows a physical issue, in which case they will be protected.The risk of fielding a first‑choice XI against a relegation rival mirrors the 2013 Wigan experience, when the club won the FA Cup but suffered relegation three days later – a bittersweet double that highlighted the fine line between triumph and disaster.Leeds have failed to win any of their last six Premier League matches, drawing four, a run that has stalled momentum. A victory could act as a catalyst to change the narrative as the season draws to a close.Injury concerns loom over striker Dominic Calvert‑Lewin, who is undergoing a hamstring scan. The England international, who netted seven goals in six games at the end of 2025, has managed only two league goals this season. A fit Calvert‑Lewin could revive Leeds’ hopes of reaching their first FA Cup semi‑final since 1987 and keep his World Cup aspirations alive.The goalkeeping position also remains unsettled. After losing his starting spot to Karl Darlow, Lucas Perri has featured solely in the FA Cup this year, leaving the decision on who starts for the West Ham tie open.Financial pressures add urgency to Farke’s decisions. Leeds’ latest accounts reveal a £49.2 million pre‑tax loss for the year ending June 2025, and a costly stadium expansion project that would be jeopardised by relegation. This backdrop explains the psychological blow of a 1‑0 loss to an under‑strength Sunderland side earlier in the month.Farke believes a deep FA Cup run could erase lingering self‑doubt. "If we secure Premier League survival and go further in the FA Cup, we can write a special chapter for this club," he said, urging his squad to seize the chance to make history.

Tiger Woods, the renowned golfer, was arrested on March 27 for driving under the influence (DUI) in Florida after his car crashed on a residential road. According to body camera footage, Woods told a Sheriff's deputy that he was 'talking to the president' during the incident.The footage shows Woods appearing astonished as he was handcuffed after failing a sobriety test. He was found to have hydrocodone in his possession, a painkiller that contains an opioid. Woods claimed he had taken 'a few' medications earlier in the day but denied drinking any alcohol.Woods, 50, pleaded not guilty to the charges and later announced that he would be stepping away indefinitely 'to seek treatment and focus on my health'. The incident has raised concerns about Woods' health and well-being, particularly given his history of surgeries, including seven back surgeries and over 20 surgeries on his right leg.

Rising fortunes among the ultra‑rich under the Trump administration have ignited a wave of tax‑reform campaigns across the United States. In California, volunteers like Karen Sanchez are gathering signatures for a one‑time 5% wealth tax targeting the state’s 200‑plus billionaires to offset federal cuts to hospitals, education and food‑assistance programs.At least ten states are exploring similar measures. Washington recently enacted its first income‑tax aimed at roughly 20,000 millionaire households, while Massachusetts and Minnesota already channel wealth‑tax proceeds into preschool, K‑12 meals and transportation infrastructure.On the federal front, Senators Bernie Sanders and Representative Ro Khanna have introduced the “Make Billionaires Pay Their Fair Share Act,” proposing an annual 5% levy on billionaire net worth. Khanna argues that the ultra‑wealthy fund private health insurers, defense contractors and political campaigns, creating a stark fairness gap.Data from Oxfam shows that in the twelve months after Trump’s re‑election, billionaire fortunes grew at a rate three times faster than the average annual growth of the previous five years. Meanwhile, the federal minimum wage has remained stagnant at $7.25 for fifteen years, underscoring the widening economic divide.A Data for Progress poll released last fall found that 70% of Americans believe the economic system favours corporations and the wealthy. “People are angry and want change,” says Amy Hanauer of the Institute on Taxation and Economic Policy (ITEP), noting that activists are leveraging every level of government to seek relief.The movement draws on a two‑decade history of class‑based activism, from the Occupy Wall Street protests to Senator Sanders’ 2016 campaign that foregrounded wealth‑tax proposals. Yet inequality has deepened: CEOs of the five largest U.S. firms now earn, on average, **$52 million** annually—over a thousand times the typical worker’s salary.Political spending by billionaires has also exploded. A recent New York Times analysis reveals that billionaire contributions rose from **0.3% of campaign funds in 2008** to **19% in 2024**, amounting to more than **$3 billion** from roughly 300 ultra‑rich donors, many of whom supported candidates opposing wealth taxes, including former President Donald Trump.The war in Iran has further inflamed resentment, with the United States spending **$11.3 billion** in the first week of bombardment—far exceeding the annual budgets of agencies such as the CDC, EPA and the National Cancer Institute.Local victories are feeding the momentum. New York City’s mayoral race saw Zohran Mamdani win on a platform that includes taxing the rich to fund affordable housing, groceries and transit. Councilmember Chi Ossé led a 1,500‑person march to the state capitol, urging Governor Kathy Hochul to permit a city‑level millionaire tax, a move that now has backing from some state Democrats.Beyond New York, states like Rhode Island, Hawaii, Pennsylvania, Virginia, Illinois and New Mexico are debating various wealth‑tax mechanisms, including the popular “mansion tax” on high‑value home sales. Currently, **17 localities** have adopted such taxes, most passed between 2018 and 2023.California’s gubernatorial race has become a flashpoint. Billionaire‑backed candidates Matt Mahan and Tom Steyer are vying to replace Governor Gavin Newsom, with the tech elite—such as Sergey Brin and Joe Lonsdale—pouring money into campaigns opposing the billionaire tax. Of the 30 billionaires who have contributed to the race, **25 supported Mahan**, who has positioned himself as a staunch anti‑tax candidate.For Sanchez, the stakes are personal. The proposed tax seeks to replace **$100 billion** in federal health‑care funding cut by Trump’s “One Big Beautiful Bill Act,” which threatens hospital closures and layoffs in the nation’s fourth‑largest economy. She aims to collect **875,000 signatures** by late June to secure the initiative on the November ballot.“It’s creating a network of groups all working toward a common good,” Sanchez says, reflecting a broader sentiment that collective action could finally translate the public’s demand for fiscal fairness into concrete policy.

Bath’s historic Farleigh House training centre has been spruced up this week with black flags fluttering alongside a new “Choose Greatness” banner, signalling the club’s ambition as they approach a Champions Cup last‑16 tie with Saracens. For Max Ojomoh, the atmosphere feels like a personal challenge. Just weeks after collecting the Man of the Match award for his decisive performance against Argentina, the 25‑year‑old found himself omitted from Steve Borthwick’s Six Nations squad. Ojomoh believes that a dominant display for Bath – especially after the 62‑15 demolition of Saracens in the Premiership – could revive his England prospects, but he also acknowledges that national selectors may have a specific back‑line profile in mind for the upcoming World Cup. Reflecting on his Argentina heroics, Ojomoh said, “If that was my final Test, I’m happy to have left a mark on international rugby.” Yet the disappointment of watching England lose to Ireland from a Moroccan pub underscores how close the margins are for a player on the fringe. He explained the selection dilemma: with centre Ollie Lawrence returning from injury, the squad needed a more physical ball‑carrier, and Ojomoh’s role as a second‑receiver/playmaker meant he was the one to make way. England’s coaching staff have asked him to sharpen three key areas – post‑contact metres, defensive intensity and overall work‑rate. While these are valid targets, Ojomoh points out that few English centres combine his blend of pace, vision and creative kicking. Back at Bath, his partnership with newly‑signed Finn Russell has blossomed. “When we signed Finn, I didn’t expect us to think alike on attack,” Ojomoh remarked, highlighting a shared instinct that fuels his confidence. Coach Johann van Graan’s influence is evident, with the club’s motivational signage and a focused training environment that Ojomoh describes as “single‑minded”. He hopes the upcoming match will provide a platform for a first home Champions Cup quarter‑final since 2002. Family wisdom also plays a role; his father, former England centre Steve Ojomoh, reminded him that “the cream always rises to the top”. With a business degree from the University of Bath and a hobby of online chess, the younger Ojomoh is aware that consistent club performances could shift national perception. Looking ahead, Ojomoh is determined to make the 2027 World Cup squad. He admits that obsession over selection can be self‑destructive, emphasizing the need for mental clarity and playing with the same confidence he shows in his head. As Bath prepares for the high‑stakes clash with Saracens, Ojomoh’s mantra remains clear: choose greatness, stay true to his strengths, and let his on‑field X‑factor speak for itself.